Traders Busy as Ohr Pharmaceutical Inc (OHRP) Reels on Data

OHR Pharmaceutical Inc (OHRP) touched a multi-year low today

Digital Content Group

Mar 27, 2015 at 10:50 AM

OHRP

OHR Pharmaceutical Inc (NASDAQ:OHRP) is getting bloodied up this morning, after the biotech firm's experimental eye drug fell short of its goal during a mid-stage trial. At last check, the stock was down nearly 65% at $3.08, and fresh off a multi-year low of $2.90. Shifting gears, OHRP options are flying off the shelves at 12 times the expected intraday rate.

A number of front-month calls are in the crosshairs. Specifically, the April 2.50, 10, 12.50, and 15 strikes are experiencing notable volume, with possible buy-to-open activity detected at the in-the-money strike. However, OHRP's most active option is the April 7.50 put, which is seeing a mix of buying and selling activity.

One group that's likely cheering today's technical breakdown is short sellers. Short interest on OHR Pharmaceutical Inc (NASDAQ:OHRP) grew 25% during the two most recent reporting periods, and now makes up 15.5% of the equity's total float. However, additional short selling isn't currently an option, as OHRP has been placed on the short-sale restricted list.

Follow @Schaeffers

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released!